Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial.
Trials · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansDouble-Blind MethodAlzheimer DiseaseMulticenter Studies as TopicRandomized Controlled Trials as TopicTreatment OutcomeCerebellumTheta RhythmTranscranial Magnetic StimulationTime FactorsFemaleAgedCognitionMaleMagnetic Resonance ImagingChinaElectroencephalographyAlzheimer’s diseaseTheta burst stimulationTranscranial magnetic stimulation
Come citare questo studio
Xin Zhang, Wen Li, Zhongqing Sun, Xiaomu Wang, Changgeng Song, Xiaorui Wang, Yinuo Niu, Dong Wei, Wei Zhang, Gejuan Zhang, Bei Zhang, Ling Wang, Zhirong Liu, Jingjing Zhao, Wen Jiang. (2026). Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial.. Trials. DOI: 10.1186/s13063-026-10009-w
Consulta la pubblicazione originale ↗